logo
Share SHARE
FONT-SIZE Plus   Neg

Ashland Q2 Net Profit Plummets - Quick Facts

Ashland Inc. (ASH) reported a significant plunge in its second-quarter net income to $88 million or $1.10 per share from last year's $485 million or $6.02 per share. However, excluding key items, Ashland's adjusted earnings from continuing operations rose 57 percent to $1.52 per share from $0.97 per share a year ago.

On average, 10 analysts polled by Thomson Reuters expected earnings per share of $1.39 for the quarter. Analysts' estimates typically exclude one-time items.

Sales for the second quarter improved to $2.08 billion from $1.56 billion in the prior-year quarter, whereas 8 analysts estimated revenues of $2.08 billion for the quarter.

The company stated, "We are well on track for the year and remain confident in our ability to deliver our fiscal 2014 financial targets for sales and earnings growth."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Snack and beverage giant Pepsico Inc. reported Thursday significantly higher profit in its third quarter, reflecting the absence of last year's hefty Venezuelan impairment charges, despite weak revenues. Core earnings and revenues beat market estimates. Further, the company lifted its fiscal 2016 forecast on its performance and outlook for the fourth quarter. Almost 71 percent of Americans say they don't save enough for their retirement, while around 54 percent believe they will never pay off their debt fully, according to a new national survey. The latest survey, commissioned by Experian together with Get Rich Slowly and other top U.S. personal finance... The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects.
comments powered by Disqus
Follow RTT